68 related articles for article (PubMed ID: 7892769)
1. Behavioral effects of the Ca2+/5-HT antagonist dotarizine.
Petkov VD; Belcheva S; Konstantinova E; Vaglenova J; Petkov VV
Acta Physiol Pharmacol Bulg; 1994; 20(1):9-17. PubMed ID: 7892769
[TBL] [Abstract][Full Text] [Related]
2. Memory effects of the Ca2+ and 5-HT antagonists dotarizine and flunarizine.
Petkov VD; Konstantinova E; Petkov VV; Belcheva S; Kehayov R; Vaglenova J
Acta Physiol Pharmacol Bulg; 2000; 25(2):43-50. PubMed ID: 11140170
[TBL] [Abstract][Full Text] [Related]
3. Does nitric oxide participate in the mechanism of action of dotarizine?
Petkov VD; Belcheva S; Konstantinova E; Petkov VV
Acta Physiol Pharmacol Bulg; 1998; 23(3-4):93-9. PubMed ID: 10672335
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic effects of dotarizine, a possible antimigraine drug.
Petkov VD; Belcheva S; Konstantinova E
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):659-68. PubMed ID: 9053586
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
6. Behavioral changes as a result of dotarizine or flunarizine influence on dopaminergic neurotransmission in the striatum.
Petkov VD; Petkova B
Acta Physiol Pharmacol Bulg; 1998; 23(1):21-5. PubMed ID: 10347616
[TBL] [Abstract][Full Text] [Related]
7. Effects on nociception of the Ca2+ and 5-HT antagonist dotarizine and other 5-HT receptor agonists and antagonists.
Belcheva S; Petkov VD; Konstantinova E; Petkov VV; Boyanova E
Acta Physiol Pharmacol Bulg; 1995; 21(4):93-8. PubMed ID: 8830881
[TBL] [Abstract][Full Text] [Related]
8. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAA and 5HT receptors.
Ghisleni G; Kazlauckas V; Both FL; Pagnussat N; Mioranzza S; Rocha JB; Souza DO; Porciúncula LO
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1508-15. PubMed ID: 18579279
[TBL] [Abstract][Full Text] [Related]
9. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
[TBL] [Abstract][Full Text] [Related]
10. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation.
Müller CP; Carey RJ; De Souza Silva MA; Jocham G; Huston JP
Synapse; 2002 Aug; 45(2):67-77. PubMed ID: 12112399
[TBL] [Abstract][Full Text] [Related]
11. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
[TBL] [Abstract][Full Text] [Related]
12. Effect of dotarizine on electroconvulsive shock or pentylenetetrazol-induced amnesia and on seizure reactivity in rats.
Lazarova M; Petkova B; Petkov VD
Methods Find Exp Clin Pharmacol; 1995; 17(1):53-8. PubMed ID: 7623521
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.
Montiel C; Herrero CJ; García-Palomero E; Renart J; García AG; Lomax RB
Eur J Pharmacol; 1997 Aug; 332(2):183-93. PubMed ID: 9286620
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
Pruus K; Skrebuhhova-Malmros T; Rudissaar R; Matto V; Allikmets L
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
[TBL] [Abstract][Full Text] [Related]
15. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
17. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
Jones N; Duxon MS; King SM
Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
[TBL] [Abstract][Full Text] [Related]
18. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
Briones-Aranda A; López-Rubalcava C; Picazo O
Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
[TBL] [Abstract][Full Text] [Related]
20. Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+.
Novalbos J; Abad-Santos F; Zapater P; Cano-Abad MF; Moradiellos J; Sánchez-García P; García AG
Eur J Pharmacol; 1999 Feb; 366(2-3):309-17. PubMed ID: 10082213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
